Publications by authors named "John R Teerlink"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

21,347

Total Likes

1,796

Extended Reach

1,733,775

Social Features

620
T
The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS).
Giuseppe M C Rosano, John R Teerlink, Koichiro Kinugawa, Antoni Bayes-Genis, Ovidiu Chioncel, James Fang, Barry Greenberg, Nasrien E Ibrahim, Teruhiko Imamura, Takayuki Inomata

Eur J Heart Fail· July 2025

Videos about Article: user user

2 1 181 3

View All Article and Social Media Activity
T
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Adriaan A Voors, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp

Nat Med· March 2022

Videos about Article: user user user

3 1 6 211 4 18

View All Article and Social Media Activity
P
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
Joyce N Njoroge, John R Teerlink

Circ Res· May 2021

Videos about Article: user user

2 2 57 14

View All Article and Social Media Activity
C
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
John R Teerlink, Rafael Diaz, G Michael Felker, John J V McMurray, Marco Metra, Scott D Solomon, Kirkwood F Adams, Inder Anand, Alexandra Arias-Mendoza, Tor Biering-Sørensen

January 2021

Videos about Article: user user user 1

4 5 158 4 20

View All Article and Social Media Activity
C
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure.
Daan C H Ceelen, Jozine M Ter Maaten, Geert H D Voordes, Gad Cotter, Beth A Davison, John R Teerlink

Eur J Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions.
Josephine L Harrington, Mario E Canonico, Abdelghani El Rafei, Scott D Solomon, John R Teerlink

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF Trial.
Henri Lu, Brian L Claggett, G Michael Felker, John J V McMurray, John R Teerlink

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Mild and Moderate Aortic Stenosis in Acute Heart Failure: Insights From RELAX-AHF-2.
Constantijn S Venema, Marco Metra, Laura Staal, Iris E Beldhuis, Gad Cotter, John R Teerlink

J Card Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article 'Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?'.
Giuseppe M C Rosano, Antoni Bayes-Genis, Koichiro Kinugawa, John R Teerlink, Marco Metra

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial.
Misato Chimura, Kieran F Docherty, Pardeep S Jhund, Mingming Yang, Ryohei Ono, John R Teerlink

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2).
Adriaan A Voors, Marco Metra, Douwe Postmus, Barry H Greenberg, Gadi Cotter, John R Teerlink

Eur J Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke in Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis of Randomized Trials.
Guglielmo Gallone, Federica Savoca, Davide Miccoli, Michael Böhm, Gaetano Maria De Ferrari, John R Teerlink

JACC Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.
Vijay Chopra, Muhammad Shahzeb Khan, Magdy Abdelhamid, William T Abraham, Offer Amir, John R Teerlink

Heart Lung Circ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late diagnosis in cancer sparks outrage-so why not heart failure?
Antoni Bayes-Genis, Lisa Anderson, Ed Harding, Marco Metra, John R Teerlink

Eur J Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ExCITe: A Narrative Review of Motivating Factors for Residency and Fellowship Selection to Provide Insights Regarding the Waning Interest in Advanced Heart Failure and Transplant Cardiology Training.
Edan Zitelny, Mark H Drazner, Jonathan Davis, Nosheen Reza, Ersilia M Defilippis, John R Teerlink

J Card Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial.
Peter Carson, John R Teerlink, Michel Komajda, Inder Anand, Milton Packer

JACC Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis.
João Pedro Ferreira, Francisco Vasques-Nóvoa, Christiane E Angermann, Jan Biegus, Sean P Collins, John R Teerlink

Eur J Heart Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS).
Giuseppe M C Rosano, John R Teerlink, Koichiro Kinugawa, Antoni Bayes-Genis, Ovidiu Chioncel

J Card Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial.
Matteo Pagnesi, Laura Staal, Jozine M Ter Maaten, Iris E Beldhuis, Gad Cotter, John R Teerlink

JACC Heart Fail· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing Effective Trials for Acute Decompensated Heart Failure.
Johannes Grand, Tor Biering-Sørensen, John R Teerlink

JACC Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC.
Anuradha Lala, Steven Coca, Jason Feinman, Carine E Hamo, Mona Fiuzat, John R Teerlink

J Am Coll Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the Posthospital Period After Admission for Worsening Heart Failure.
Giuseppe M C Rosano, Gianluigi Savarese, Michael Böhm, John R Teerlink

JACC Heart Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and future heart failure drugs.
Leila Haghighat, Colette DeJong, John R Teerlink

Nat Cardiovasc Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2.
Karla Arevalo Gomez, Jasper Tromp, Sylwia M Figarska, Iris E Beldhuis, Gad Cotter, John R Teerlink

JACC Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
João Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, Mikhail N Kosiborod, Christiane E Angermann

Eur J Heart Fail· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee.

J Am Coll Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations.
Philip B Adamson, Melvin Echols, Ersilia M DeFilippis, Alanna A Morris, Mosi Bennett, John R Teerlink

JACC Heart Fail· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Jasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink

Eur J Heart Fail· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis